Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeability

Kenneth R. Mcleish; Frederick N. Miller; Gregory T. Stelzer; Samuel R. Wellhausen

doi:10.1007/bf00916127

journal article Sep 01, 1986

Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeability

Kenneth R. Mcleish Frederick N. Miller Gregory T. Stelzer Samuel R. Wellhausen

Inflammation Vol. 10 No. 3 pp. 321-332 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/bf00916127

Topics

No keywords indexed for this article. Browse by subject →

References

43

[1]

Hughi, T. E., andH. J. Muller-Eberhard. 1978. Anaphylatoxins: C3a and C5a.Adv. Imunol. 26:1?53. 10.1016/s0065-2776(08)60228-x

[2]

Williams, T. J., andP. J. Jose. 1981. Mediation of increased vascular permeability after complement activation-histamine-independent action of rabbit C5a.J. Exp. Med. 153:136?153. 10.1084/jem.153.1.136

[3]

Jose, P. J., M. J. Forrest, andT. J. Williams. 1981. Human C5a des arg increases vascular permeability.J. Immunol. 127:2376?2380. 10.4049/jimmunol.127.6.2376

[4]

Wedmore, C. V., andT. J. Williams. 1981. Control of vascular permeability by polymorphonuclear leukocytes in inflammation.Nature 289:646?650. 10.1038/289646a0

[5]

Williams, T. J., andM. J. Peck. 1977. Role of prostaglandin-mediated vasodilation in inflammation.Nature 270:530?532. 10.1038/270530a0

[6]

Williams, T. J., andJ. Morley. 1973. Prostaglandins as potentiators of increased vascular permeability in inflammation.Nature 246:215?217. 10.1038/246215a0

[7]

ENDOTHELIAL CONTRACTION INDUCED BY HISTAMINE-TYPE MEDIATORS

Guido Majno, Stephen M. Shea, Monika Leventhal

The Journal of cell biology 1969 10.1083/jcb.42.3.647

[8]

Gerdin, B., C. Lundberg, andG. Smedegard. 1985. Permeability-increasing ability of PAF-acether in rat skin.Inflammation 9:107?112. 10.1007/bf00915417

[9]

Blork, J., andG. Smedegard. 1983. Acute microvascular effects of PAF-acether, as studied by intravital microscopy.Eur. J. Pharmacol. 96:87?94. 10.1016/0014-2999(83)90532-0

[10]

Johnson, K. J., andP. A. Ward. 1981. Role of oxygen metabolites in immune complex injury of lung.J. Immunol. 126:2365?2369. 10.4049/jimmunol.126.6.2365

[11]

Schraufstatter, I. U., S. D. Revak, andC. G. Cochrane. 1984. Proteases and oxidants in experimental pulmonary inflammatory injury.J. Clin. Invest. 73:1175?1184. 10.1172/jci111303

[12]

Hyman, Y. G., andT. L. Vischer. 1978. Protease inhibitors reduce the reverse passive arthus reaction.Agents Actions 8:532?535. 10.1007/bf02111441

[13]

Cathcard, E. S., M. A., Scheinberg, B. A., Idelson, andW. G. Couser. 1976. Beneficial effects of methylprednisone ?pulse? therapy in diffuse proliferative lupus nephritis.Lancet 1:163?166. 10.1016/s0140-6736(76)91272-1

[14]

Dosa, S., N. P. Mallick, W. Lawler, S. A. Cairns, andI. N. Slotki 1978. The treatment of lupus nephritis by methyl prednisolone pulse therapy.Postgrad. Med. J. 54:628?632. 10.1136/pgmj.54.635.628

[15]

Bolton, W. K., andW. G. Couser. 1979. Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis.Am. J. Med. 66:495?581. 10.1016/0002-9343(79)91081-7

[16]

O'Neill, W. M., W. B. Etheridge, andA. Bloomer. 1979. High-dose corticosteroids?their use in treating idiopathic rapidly progressive glomerulonephritis.Arch. Intern. Med. 139:514?518. 10.1001/archinte.1979.03630420010007

[17]

Cole, B. R., J. T. Brocklebank, R. A. Kienstra, J. M. Kissane, andA. M. Robson. 1976. ?Pulse? methylprednisolone therapy in the treatment of severe glomerulonephritis.J. Pediatr. 88:307?314. 10.1016/s0022-3476(76)81009-8

[18]

De Vecchi, A., G. Montagnino, C. Pozzi, A. Tarantino, F. Locatelli, andC. PontiCelli. 1983. Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy.Clin. Nephrol. 19:221?227.

[19]

Miller, F. N., andD. L. Wiegman. 1977. Anesthesia induced alteration of small vessel responses to norepinephrine.Eur. J. Pharmacol. 44:331?337. 10.1016/0014-2999(77)90307-7

[20]

Miller, F. N., I. G. Joshua, andG. L. Anderson. 1982. Quantitation of vasodilator-induced macromolecular leakage by in vivo fluorescent microscopy.Microvasc. Res. 24:56?67. 10.1016/0026-2862(82)90042-5

[21]

Chadwick, C. S., and J. E.Fothergill. Fluorochromes and their conjugation with proteins.In Fluorescent Protein Training. R. C. Nairyn, editor. Livingstone, Edinburgh 4?30.

[22]

Hunter, W. M., andF. C. Greenwood. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity.Nature 194:495?496. 10.1038/194495a0

[23]

Szejda, P., W. Parce, M. S. Seeds, andD. A. Bass. 1984. Flow cytometric quantitation of oxidative product formation by polymorphonuclear leukocytes during phyagocytosis.J. Immunol. 133:3303?3307. 10.4049/jimmunol.133.6.3303

[24]

Bass, D. A., J. W. Parce, L. R. Dechatelet, P. Szejda, M. C. Seeds, andM. Thomas. 1983. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation.J. Immunol. 130:1910?1917. 10.4049/jimmunol.130.4.1910

[25]

Bjork, J., andG. Smedegard. 1984. The microvasculature of the hamster cheek pouch as a model for studying acute immune-complex-induced inflammatory reactions.Int. Arch. Allergy Appl. Immunol. 74:178?185. 10.1159/000233540

[26]

Bailey, P. J., andA. Strum. 1983. Immune complexes and inflammation?a study of the activity of antiinflammatory drugs in the reverse passive Arthus reaction in the rat.Biochem. Pharmacol. 32:475?481. 10.1016/0006-2952(83)90526-9

[27]

Butler, K., andG. P. Lewis. 1976. The effect of antiinflammatory compounds on the biochemical changes in the Arthus reaction.J. Pathol. 119:175?182. 10.1002/path.1711190307

[28]

Mansour, A., D. S. Nelson. 1979. Effect of hydrocortisone, cyclophosphamide, azathioprine and methotrexate on cutaneous delayed and arthus hypersensitivity in the rat.Int. Arch. Allergy Appl. Immunol. 60:50?59. 10.1159/000232322

[29]

Carter, G. W., M. K. Martin, R. A. Krause, andP. R. Young. 1982. The effects of antiinflammatory and other agents on the rat dermal Arthus reaction.Res. Commun. Chem. Pathol. Pharmacol. 35:189?207.

[30]

Chang, Y. H., andI. G. Otterness. 1981. Effects of pharmacologic agents on the reversed passive Arthus reaction in the rat.Eur. J. Pharmacol. 69:155?164. 10.1016/0014-2999(81)90410-6

[31]

Issekutz, A. C. 1983. Comparison of the effects of glucocorticoid and indomethacin treatment on the acute inflammatory reaction in rabbits.Immunopharmacology 5:183?195. 10.1016/0162-3109(83)90026-7

[32]

Macgregor, R. R., P. J. Spagnuolo, andA. L. Lentnek. 1974. Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system.N. Engl. J. Med. 291:642?646. 10.1056/nejm197409262911302

[33]

Theme, T. R., A. Mirkovich, P. Maloney, andD. A. Goodwin. 1982. In vivo and in vitro effects of dexamethasone on leukocyte migration in the rat adjuvant arthritis model.Inflammation 6:371?386. 10.1007/bf00917308

[34]

Clark, R. A. F., J. I. Gallin, andA. S. Fauci. 1979. Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis.Blood 53:633?641. 10.1182/blood.v53.4.633.633

[35]

Hawkins, D. 1974. Neutrophilic leukocytes in immunologic reactions in vitro. III. Pharmacologic modulation of lysosomal constituent release.Clin. Immunol. Immunopathol. 2:141. 10.1016/0090-1229(74)90034-8

[36]

Ignarro, L. J., andS. Y. Cech. 1975. Lysosormal enzyme secretion from human neutrophils mediated by cyclic GMP: Inhibition of cyclic GMP accumulation and neutrophil function by glucocorticosteroids.J. Cyclic Nudeotide Res. 1:283.

[37]

Smith, R. J. 1977. Phagocytic release of lysosomal enzymes from guinea pig neutrophils-regulation by corticosteroids, autonomic neurohormones and cyclic nucleotides.Biochem. Pharmacol. 26:2001. 10.1016/0006-2952(77)90009-0

[38]

Lehmeyer, J. E., R. B. Johnston. 1978. Effect of antiinflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgG.Clin. Immunol. Immunopathol. 9:482. 10.1016/0090-1229(78)90144-7

[39]

Levine, P. H., J. C. Hardin, K. L. Scoon, andN. I. Krinsky. 1981 Effect of corticosteroids on the production of Superoxide and hydrogen peroxide and the appearance of chemiluminescence by phagocytosing polymorphonuclear leukocytes.Inflammation 5:19?27. 10.1007/bf00910776

[40]

Hong, S. L., andL. Levine. 1976. Inhibition of arachidonic acid release from cells as the biochemical action of antiinflammatory corticosteroids.Proc. Natl. Acad. Sci. U.S.A. 73:1730. 10.1073/pnas.73.5.1730

[41]

Ley, K., andK. E. Arfors. 1982. Changes in macromolecular permeability by intravascular generation of oxygen-derived free radicals.Microvasc. Res. 24:25?33. 10.1016/0026-2862(82)90039-5

[42]

Del Maestro, R. F., J. Bjork, andK. E. Arfors. 1981. Increase in microvascular permeability induced by enzymatically generated free radicals.Microvasc. Res. 22:239?254. 10.1016/0026-2862(81)90095-9

[43]

Del Maestro, R. F., J. Bjork, andK. E. Arfors. 1981. Increase in microvascular permeability induced by enzymatically generated free radicals. II. Role of Superoxide anion radical, hydrogen peroxide, and hydroxyl radical.Microvasc. Res. 22:255?270. 10.1016/0026-2862(81)90096-0

Metrics

11

Citations

43

References

Details

Published: Sep 01, 1986
Vol/Issue: 10(3)
Pages: 321-332
License: View

Authors

Cite This Article

Kenneth R. Mcleish, Frederick N. Miller, Gregory T. Stelzer, et al. (1986). Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeability. Inflammation, 10(3), 321-332. https://doi.org/10.1007/bf00916127

Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeability

You May Also Like